{
  "ticker": "JNJ",
  "target_date": "2025-09-09",
  "actual_date": "2025-09-09",
  "collected_at": "2025-12-08T12:15:28.573020",
  "price": {
    "open": 176.88,
    "high": 176.97,
    "low": 175.34,
    "close": 175.84353637695312,
    "volume": 6005700,
    "change_1d_pct": -0.66,
    "change_7d_pct": 0.86,
    "change_30d_pct": 7.24
  },
  "technicals": {
    "rsi_14": 52.31,
    "sma_20": 175.36,
    "sma_50": 167.0,
    "macd": 2.709,
    "macd_signal": 3.199,
    "macd_histogram": -0.489,
    "bb_upper": 179.23,
    "bb_lower": 171.49,
    "price_vs_sma20_pct": 0.28,
    "price_vs_sma50_pct": 5.29,
    "volume_ratio": 0.75
  },
  "fundamentals": {
    "market_cap": 487496777728,
    "pe_ratio": 19.530888,
    "forward_pe": 19.088678,
    "price_to_book": 6.141379,
    "price_to_sales": 5.29031,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.63,
    "pct_from_52w_low": 43.83
  },
  "macro": {
    "spy": {
      "price": 648.53,
      "change_1d_pct": 0.23,
      "change_7d_pct": 0.82
    },
    "vix": {
      "level": 15.04,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.07
    },
    "dollar_index": {
      "level": 97.79
    },
    "gold": {
      "price": 3643.3
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Tylenol maker\u2019s stock lost billions\u00a0after\u00a0a rumor linking\u00a0the medicine\u00a0to autism. Wall Street says buy the dip as one bank sees a \u2018major overreaction\u2019",
      "source": "Yahoo",
      "datetime": 1757454353,
      "summary": "Canaccord Genuity went on social media to gauge the reaction. Even the MAHA crowd was mixed on this one.",
      "url": "https://finnhub.io/api/news?id=297d08d7cc7376d24684cda5e204de24165fa60d67345f2cc64b98ea65a3cb7f"
    },
    {
      "headline": "Top Stock Reports for Johnson & Johnson, SAP & Coca-Cola",
      "source": "Yahoo",
      "datetime": 1757454060,
      "summary": "Zacks Research Daily spotlights Johnson & Johnson, SAP, and Coca-Cola three global leaders navigating growth opportunities and near-term headwinds.",
      "url": "https://finnhub.io/api/news?id=840576d5f5027df62cecd3db12fb2bd7dc65c825832749b529efeaa9ae6a386c"
    },
    {
      "headline": "U.S. FDA approval of INLEXZO\u2122 (gemcitabine intravesical system) set to transform how certain bladder cancers are treated",
      "source": "Yahoo",
      "datetime": 1757452680,
      "summary": "Johnson & Johnson (NYSE:JNJ) announced today the U.S. Food and Drug Administration (FDA) approved INLEXZO\u2122 (gemcitabine intravesical system), a new, potentially practice-changing approach for treating patients with certain types of bladder cancer, addressing the need for additional options following",
      "url": "https://finnhub.io/api/news?id=b06ba26137bdadabc093ae76b20899bc54e081e36f3d24d3358027a9bfc9c5e4"
    },
    {
      "headline": "Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q2 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1757451534,
      "summary": "See an update on Prem Watsa's latest 13F portfolio moves, find out his top stock picks, global strategy, and key insights for focused, long-term investing.",
      "url": "https://finnhub.io/api/news?id=628bb2894b5e7b55dcceee727c68da960b38694f77e54a37375520f34a37c29b"
    },
    {
      "headline": "Are You Looking for a High-Growth Dividend Stock?",
      "source": "Yahoo",
      "datetime": 1757436303,
      "summary": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",
      "url": "https://finnhub.io/api/news?id=32279ceacfa690c88d99f4c46ccc6be63ebc2c1e2570d4a27723039e31834370"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "8-K",
      "date": "2025-09-09",
      "description": "jnj-20250908.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000190/jnj-20250908.htm"
    },
    {
      "form": "4",
      "date": "2025-09-05",
      "description": "xslF345X05/wk-form4_1757109644.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/xslF345X05/wk-form4_1757109644.xml"
    },
    {
      "form": "4",
      "date": "2025-09-03",
      "description": "xslF345X05/wk-form4_1756934034.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000184/xslF345X05/wk-form4_1756934034.xml"
    },
    {
      "form": "4",
      "date": "2025-08-25",
      "description": "xslF345X05/wk-form4_1756163533.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000182/xslF345X05/wk-form4_1756163533.xml"
    },
    {
      "form": "4",
      "date": "2025-08-18",
      "description": "xslF345X05/wk-form4_1755555550.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000180/xslF345X05/wk-form4_1755555550.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}